• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

    326.75 -2.18 (-0.66%)
    Streaming Delayed Price Updated: 3:02 PM EST, Feb 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 417,350
    Open 315.00
    Bid (Size) 324.42 (200)
    Ask (Size) 329.08 (300)
    Prev. Close 328.93
    Today's Range 293.01 - 333.84
    52wk Range 26.70 - 335.75
    Shares Outstanding 44,712,538
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Praxis Medicines Q4 2025 Earnings Call Transcript ↗
    Praxis Medicines Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings Economy
    Praxis Precision Medicines (NASDAQ:PRAX) Reports Q4 2025 Results Amid Key Regulatory Milestones ↗
    Via Chartmill

    Performance

    YTD
    +14.1%
    +14.1%
    1 Month
    +0.8%
    +0.8%
    3 Month
    +72.6%
    +72.6%
    6 Month
    +622.1%
    +622.1%
    1 Year
    +315.4%
    +315.4%

    More News

    Read More
    News headline image
    Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites ↗
    Via Stocktwits
    News headline image
    Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Soleus Adds a Significant Number of Celcuity Shares ↗
    Via The Motley Fool
    News headline image
    Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
    Via MarketMinute
    Topics Artificial Intelligence ETFs Initial Public Offering
    News headline image
    Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines, Inc. Announces Proposed Public Offering
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Why Praxis Precision Medicines Stock Popped Today ↗
    Via The Motley Fool
    News headline image
    Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
    Via MarketMinute
    Topics ETFs Intellectual Property
    News headline image
    Praxis Stock Surges On FDA Breakthrough Status For Essential Tremor Drug ↗
    Via Benzinga
    News headline image
    Traders are paying attention to the gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    Why Did Praxis Precision Stock Surge 12% Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies
    From Praxis Precision Medicines, Inc.
    Via GlobeNewswire
    News headline image
    What's going on in today's session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Praxis Precision Medicines, Inc. - Common Stock publicly traded?
    Yes, Praxis Precision Medicines, Inc. - Common Stock is publicly traded.
    What exchange does Praxis Precision Medicines, Inc. - Common Stock trade on?
    Praxis Precision Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Praxis Precision Medicines, Inc. - Common Stock?
    The ticker symbol for Praxis Precision Medicines, Inc. - Common Stock is PRAX on the Nasdaq Stock Market
    What is the current price of Praxis Precision Medicines, Inc. - Common Stock?
    The current price of Praxis Precision Medicines, Inc. - Common Stock is 326.75
    When was Praxis Precision Medicines, Inc. - Common Stock last traded?
    The last trade of Praxis Precision Medicines, Inc. - Common Stock was at 02/19/26 03:02 PM ET
    What is the market capitalization of Praxis Precision Medicines, Inc. - Common Stock?
    The market capitalization of Praxis Precision Medicines, Inc. - Common Stock is 14.61B
    How many shares of Praxis Precision Medicines, Inc. - Common Stock are outstanding?
    Praxis Precision Medicines, Inc. - Common Stock has 15B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.